Neuroprotection and pharmacotherapy for motor symptoms in Parkinson's disease
- 31 August 2004
- journal article
- review article
- Published by Elsevier in The Lancet Neurology
- Vol. 3 (8) , 466-474
- https://doi.org/10.1016/s1474-4422(04)00823-3
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Direct economic impact of Parkinson's disease: A research survey in the United KingdomMovement Disorders, 2003
- Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET studyAnnals of Neurology, 2003
- Resource use and costs in a Swedish cohort of patients with Parkinson's diseaseMovement Disorders, 2002
- Improved accuracy of clinical diagnosis of Lewy body Parkinson’s diseaseNeurology, 2001
- Health related quality of life in Parkinson's disease: a prospective longitudinal studyJournal of Neurology, Neurosurgery & Psychiatry, 2000
- Cost-effectiveness analysis in Parkinson's disease: Determining the value of interventionsMovement Disorders, 2000
- The quality of life in Parkinson's diseaseMovement Disorders, 2000
- Accuracy of diagnosis in patients with presumed Parkinson's diseaseAge and Ageing, 1999
- Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.Journal of Neurology, Neurosurgery & Psychiatry, 1992
- Accuracy of Clinical Diagnosis in Parkinsonism — A Prospective StudyCanadian Journal of Neurological Sciences, 1991